Novome Biotechnologies

Novome Biotechnologies Overview

Founded 2016
Founded
Status Private
Employees 13
Employees
Latest Deal Type Series A1
Latest Deal Amount $33M
Latest Deal Amount
Investors 6

Novome Biotechnologies General Information

Description

Provider of a drug discovery platform intended to develop cell-based therapeutics. The company's platform utilizes engineered gut bacteria for treating diseases, enabling doctors to help patients to achieve long-term health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • 279 East Grand Avenue
  • Suite 420
  • South San Francisco, CA 94080
  • United States

Novome Biotechnologies Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novome Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A1) 06-Jan-2020 $33M 000.00 0000 Completed Generating Revenue
5. Grant 27-Aug-2019 00000 00000 Completed Startup
4. Grant 15-Aug-2018 00000 00000 Completed Startup
3. Seed Round 09-Mar-2018 00.00 00000 Completed Startup
2. Angel (individual) 09-Jan-2017 $536K $536K Completed Startup
1. Grant 15-Dec-2016 $225K Completed Startup

Novome Biotechnologies Cap Table

To view Novome Biotechnologies‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 00,000,000 00.000000 00.00 00.00 00 00.00 000
Series A-3 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 2,119,798 $0.001000 $1.65 $1.65 1x $1.65 10.91%

Novome Biotechnologies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 00 00000 0000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 Venture Capital-Backed Stockholm, Sweden 0 00000 00000000000 00000

Novome Biotechnologies Executive Team (6)

Name Title Board Seat Contact Info
William DeLoache Ph.D Co-Founder, Chief Scientific Officer & Board Member
Shu Kurosaki Controller
Liz Shepherd Ph.D Co-Founder
Zachary Russ Ph.D Co-Founder
Weston Whitaker Ph.D Co-Founder, Vice President of Research & Board Observer

Novome Biotechnologies Board Members (9)

To view Novome Biotechnologies‘s full board member team, request access »
Name Representing Role Since
Andrew Schwab 5AM Ventures Board Member 000 0000
Blake Wise Self Chief Executive Officer & Board Member 000 0000
Daniel Janney Alta Partners Board Member 000 0000
Kiersten Stead Ph.D Data Collective Board Member 000 0000
Mira Chaurushiya Ph.D 5AM Ventures Board Observer 000 0000

2 Former Board Members

Novome Biotechnologies Investors (6)

To view Novome Biotechnologies‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
DCVC Bio Venture Capital Minority 000 0000 000000 0
Mayo Clinic VC-Backed Company Minority 000 0000 000000 0
5AM Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial